Reveal Research Institute

Dallas, Texas 75235

2 studies enrolling now · 5 studies all time

What they study most

Atopic Dermatitis, Chronic Inducible Urticaria, Chronic Spontaneous Urticaria, Chronic Spontaneous Urticaria (CSU), Cutaneous Squamous Cell Carcinoma (CSCC), Plaque Psoriasis

Studies at this site

• A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines — Recruiting now
• Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma — Recruiting now
• A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis — Running, not enrolling
• Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU) — Running, not enrolling
• A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis — Completed